Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Evans

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Intensive Care Medicine|March 31, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|February 15, 2023
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 PandemicGeorge L Anesi, Adair Andrews, He Julia Bai, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
The Lancet. Infectious Diseases|November 14, 2021
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi methodPrashant Nasa, Elie Azoulay, Arunaloke Chakrabarti, et al.
Journal of Medicinal Chemistry|April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Intensive Care Medicine|March 31, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|April 1, 2020
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)Waleed Alhazzani, Morten Hylander Møller, Yaseen M Arabi, et al.
Critical Care Medicine|February 15, 2023
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 PandemicGeorge L Anesi, Adair Andrews, He Julia Bai, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
The Lancet. Infectious Diseases|November 14, 2021
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi methodPrashant Nasa, Elie Azoulay, Arunaloke Chakrabarti, et al.
Journal of Medicinal Chemistry|April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Critical Care Medicine|February 8, 2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First UpdateWaleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Pageof 13